Pharma M&A – Actavis to Acquire Warner Chilcott
May 20, 2013 at 11:32 AM EDT
On Monday, generic drug maker Actavis Inc. (NYSE: ACT ) announced plans to purchase specialty pharmaceutical company Warner Chilcott (NASDAQ: WCRX ) in an all-stock deal valued around $8.5 billion. Actavis management will lead the combined company. The move is particularly notable for Actavis, a company that has spurned
